Arkolith/Insider Trading/CYCN/Form 4

Hecht Peter M

Chief Executive Officer, Director, 10% OwnerCyclerion Therapeutics, Inc. (CYCN) · full profile →Form 4 · filed May 22, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 19, 2023Grant(A)225K$8.68$2.0M327K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 19, 2023Grant(A)351K$8.68$3.0M351K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-23-026101) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML